大剂量氨甲蝶呤及甲酰四氢叶酸钙解救治疗骨肉瘤20例分析  被引量:1

ANALYSIS OF 20 CASES OF OSTEOSARCOMA FURTHER TREATED WITH HD MTX CFR

在线阅读下载全文

作  者:房永宏[1] 卫永泽[1] 杨平[1] 李雪丽 王秀丽[1] 姚清丽 王敏杰[1] 李习芬[1] 

机构地区:[1]山西省肿瘤医院

出  处:《山西医药杂志》1997年第3期201-203,共3页Shanxi Medical Journal

摘  要:报道了大剂量氨甲蝶呤及甲酰四氢叶酸钙解救(HD-MTX-CFR)治疗骨肉瘤20例分析。所有病例均经病理学诊断确诊,MTX每疗程剂量200mg/kg,静滴4小时~6小时,静滴MTX完后6小时~12小时开始行CF解救,毒副作用较轻,无一例发生意外,骨肉瘤行大剂量MTX化疗疗效是肯定的,联合化疗效果更佳,但剂量不宜太低,只要注意“水化”及尿液“碱化”,CF定时解救,此疗法是安全的。patients with pathologically confirmed osteosarcoma further treated with the high dose Methotrexate and Citrovorum Factor Rescue were reported.200mg/kg MTX was used for each course,6h~12h after the intravenous MTX drip which lasted 4h~16h,CFR started in use.No one died of complication related to this therapy with slight toxic reaction.It is effective to use high dose chemical therapy for osteosarcoma,MTX is one of the effectual drugs.Combined chemotherapy with high dosage is the better.If only you pay attention to the hydration and alkalinization and timely treatment of CFR,this therapy is safe.

关 键 词:氨甲蝶呤 甲酰四氢叶酸钙 骨肉瘤 急救 剂量 

分 类 号:R738.105[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象